|
US6150328A
(en)
|
1986-07-01 |
2000-11-21 |
Genetics Institute, Inc. |
BMP products
|
|
US6291206B1
(en)
|
1993-09-17 |
2001-09-18 |
Genetics Institute, Inc. |
BMP receptor proteins
|
|
AU689184B2
(en)
|
1993-12-07 |
1998-03-26 |
Genetics Institute, Llc |
BMP-12, BMP-13 and tendon-inducing compositions thereof
|
|
WO1999061044A1
(en)
*
|
1998-05-28 |
1999-12-02 |
The Board Of Trustees Of The University Of Arkansas |
Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
|
|
ATE481487T1
(de)
*
|
1998-11-27 |
2010-10-15 |
Ucb Sa |
Zusammensetzungen und verfahren zur erhöhung der knochenmineralisierung
|
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
|
DK1223990T3
(da)
|
1999-10-15 |
2004-11-29 |
Inst Genetics Llc |
Formuleringer af hyaluronsyre til tilförsel af osteogene proteiner
|
|
US7226587B2
(en)
|
2001-06-01 |
2007-06-05 |
Wyeth |
Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
|
|
JP2004532640A
(ja)
*
|
2001-06-05 |
2004-10-28 |
オークランド ユニサーヴィスィズ リミテッド |
肺機能および障害の評価のための方法および組成物
|
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
|
US20040176287A1
(en)
*
|
2001-06-08 |
2004-09-09 |
Harrison Andrew James |
Bmp binding proteins for use in bone or cartilage regeneration
|
|
GB2385052A
(en)
|
2002-02-05 |
2003-08-13 |
Leuven K U Res & Dev |
Treatment of spondyloarthropathies
|
|
US7193069B2
(en)
*
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
WO2004062621A2
(en)
*
|
2003-01-13 |
2004-07-29 |
Georgia Tech Research Corporation |
Anti-inflammatory agents and methods of their use
|
|
JP2008500373A
(ja)
*
|
2004-05-27 |
2008-01-10 |
アクセルロン ファーマ インコーポレーテッド |
ケルベロス（Ｃｅｒｂｅｒｕｓ）／ココ（Ｃｏｃｏ）誘導体およびそれらの使用
|
|
US9045553B2
(en)
|
2004-05-27 |
2015-06-02 |
Acceleron Pharma, Inc. |
Cerberus/Coco derivatives and uses thereof
|
|
KR20080011289A
(ko)
*
|
2005-05-10 |
2008-02-01 |
시너젠즈 바이오사이언스 리미티드 |
폐기능 및 폐질환을 평가하기 위한 성분 및 평가 방법
|
|
WO2006123955A2
(en)
*
|
2005-05-19 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms
|
|
CA2608158A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
WO2006123943A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods of analysis of polymorphisms and uses thereof
|
|
CA2652549A1
(en)
*
|
2006-05-17 |
2007-12-13 |
Stryker Corporation |
Use of a soluble morphogenic protein complex for treating cartilage defects
|
|
CA2671983A1
(en)
|
2006-12-08 |
2009-06-19 |
Acceleron Pharma Inc. |
Uses of cerberus, coco and derivatives thereof
|
|
CN105759056B
(zh)
*
|
2016-04-06 |
2017-11-14 |
四川大学华西医院 |
一种肺癌筛查试剂盒
|
|
US10961305B2
(en)
|
2016-12-21 |
2021-03-30 |
Mereo Biopharma 3 Limited |
Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
|